Insiders tell CNN the FDA’s AI is “hallucinating” studies and can’t access key documents. Agency leaders insist the AI is ...

But three of those FDA employees told CNN that Elsa just makes up nonexistent studies, something commonly referred to in AI ...

Insiders at the Food and Drug Administration are ringing alarm bells over the agency's use of an AI to fast-track drug ...

With reports that FDA’s AI Elsa is “confidently hallucinating” studies that don’t exist, the use of AI to streamline drug ...

FDA officials say the assistant is flawed, just as the Trump administration stresses AI adoption in healthcare.

The FDA's generative AI, Elsa, has a massive hallucination problem, according to the agency's employees themselves.

In recent years, Artificial Intelligence (AI) has made significant strides across various sectors, providing innovative solutions and enhancing efficiency. However, ...

Hallucinations are a known problem with generative AI models—and Elsa is no different, according to Jeremy Walsh, the head of ...

The Food and Drug Administration (FDA) is looking to AI to solve the problem of lengthy approval processes, as the Trump ...

The FDA officials wrote that AI held the promise to “radically increase efficiency” in examining as many as 500,000 pages submitted for approval decisions. Advertising ...

The Food and Drug Administration (FDA) is looking to AI to solve the problem of lengthy approval processes, as the Trump administration invests in even more automation amid thousands of federal ...

FDA officials want to leverage AI for drug and device approval, animal testing, and data processing, ... FDA wants to use AI to speed up drug approval process. June 11, 2025 at 1:58 PM.